Clinical Trial: TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736846) titled 'TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends' on July 20.

Brief Summary: TRESPECT is an international, multicenter, observational registry designed to describe the real-world use, effectiveness, and tolerability of parenteral treprostinil in adults with newly diagnosed pulmonary arterial hypertension (PAH). The registry will include patients who initiated subcutaneous or intravenous treprostinil within 12 months of PAH diagnosis.

Both retrospective and prospective data will be collected from routine clinical care. Data will include patient characteristics, PAH treatment patterns, treprostinil dosing and rout...